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Minireview
Scratching the (T cell) surface
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Abstract
Using a genome-scale approach to study transcription levels in a human CD8+ T-cell clone, a
recent study has suggested that the repertoire of molecules on the surface of T cells is close to
being completely characterized. 
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Over the last few years technological advances have made it
possible to study, in parallel, the expression of thousands of
genes in cells, tissues or organisms. While this genome-scale
approach to gene-expression analysis has been touted by some
as the new ‘golden era’ of hypothesis-unlimited discovery-
driven research [1], it is apparent that our ability to make
sense of the vast accumulations of data does not always keep
up with our ability to generate them. Many groups have used
technologies such as microarrays or serial analysis of gene
expression (SAGE) to analyze gene expression in cells of the
immune system. A recent article by Evans et al. in Immunity
[2] attempting to expand beyond the simple description of
differential gene-expression patterns arrives at a bold con-
clusion. The article’s title is intriguing - The T-cell surface -
how well do we know it? - and the conclusion is that we
know it quite well.
Not surprisingly, molecules on the surface of T cells are of
great interest to immunologists. Much information has been
generated about T-cell-specific surface molecules and their
function since the first monoclonal antibodies against leuko-
cyte surface markers were made in the late 1970s. Attempts
to compare the specificities of different monoclonal antibod-
ies and to identify their targets led to the development of the
cluster of differentiation (CD) nomenclature [3]. Most of the
CD antigens turned out to be proteins (a few CD antibodies
detect carbohydrate modifications) and the respective genes
have been cloned in both humans and mice. Over time the CD
system thus transformed into a classification for leukocyte
surface molecules, rather than antibodies. Currently, there
are 247 assigned CDs [4]. Almost 200 additional molecules
are being considered for CD status during the current Eighth
International Workshop on Human Leukocyte Differentia-
tion Antigens that will culminate in the HLDA8 Conference
in Adelaide, Australia in December 2004 [5]. 
The molecules on the surface of T cells belong to very diverse
structural and functional classes, and include components of
the immunoreceptors on T, B and NK cells, adhesion mole-
cules, and cytokine and chemokine receptors. Some CDs have
proven to be useful markers of subpopulations of cells with
strikingly different functions. Most T cells express CD3 and an
   T-cell receptor (TCR) paired with either the CD4 or the
CD8 molecule as co-receptor. CD4+    T cells recognize anti-
gens presented by antigen-presenting cells in the context of
major histocompatibility complex (MHC) class II molecules.
Their main effector function is the production of cytokines and
the facilitation of immune responses. A subclass of CD4+ T cells
that has recently gained attention comprises regulatory/sup-
pressor T cells, which are characterized by the constitutive
expression of CD25 - the  -chain of the interleukin 2 (IL-2)
receptor. These cells are thought to negatively regulate immune
responses and to prevent uncontrolled autoimmunity. CD8+
   T cells recognize antigens in the context of MHC class I mol-
ecules, which are expressed on most somatic cells. Upon activa-
tion, CD8+ T cells develop into cytolytic T lymphocytes (CTLs)
ready to kill cells infected by intracellular pathogens, such as
viruses, or eradicate tumors cells. In their article on the T-cell surface, Evans et al. [2] used
SAGE to study gene expression in a human CD8+ CTL clone.
The SAGE library that was generated (referred to as the CTL
library) contained 71,174 SAGE tags representing 20,204
distinct sequences. This number was estimated to cover all
of the transcripts whose expression level was at or above
0.008% of the transcriptome (that is having at least 22
copies per cell). The library included 111 genes with, or being
considered for, CD status. Several pairwise comparisons
with unrelated SAGE libraries were then performed. 
The central analysis of the paper starts with a comparison of
the CTL library with a library derived from cerebellum;
1,098 transcripts were significantly more abundant in the
CTL library. Among these, about a quarter of the transcripts
with known function coded for proteins involved in
protein/mRNA synthesis, a result that was thought to reflect
the proliferating versus non-proliferating character of the
two cell/tissue types (CTL versus cerebellum). Interestingly,
the set of genes that was highly differentially expressed in
the CTLs was enriched for surface markers, signaling mole-
cules and soluble mediators. In an attempt to find a core set
of CTL-specific genes, additional comparisons were per-
formed between the CTL library and SAGE libraries from
ovary epithelium (as a type of proliferating cell) and a panel
of tumor libraries. This resulted in a shortened list of 387
CTL-specific transcripts. 
Notably, at all stages of comparison 42-45% of the tran-
scripts lacked an assigned function. Of the known genes in
the final list of 387 specific transcripts in the CTL library,
27% were cell-surface molecules, including TCR compo-
nents, CD2, CD5, and CD8. Evans et al. [2] then asked how
many of the unknown CTL-specific transcripts encoded
surface molecules. Sequences representing UniGene clusters
[6] were analyzed for signatures of surface molecules by
domain analysis, looking for transmembrane regions or
other domains characteristic of leukocyte surface molecules,
and by BLAST searches for related genes with known func-
tion. Surprisingly, only 2 of the 97 (2%) UniGene clusters
analyzed showed some potential for encoding novel surface
molecules. The authors therefore concluded that “the cell-
type-specific composition of the resting CD8+ T-cell surface
is now largely defined.”
How complete and cell-type-specific is this list of 387 genes?
The CTL SAGE library of 20,204 transcripts represents the
transcriptome of the CTL clone. A detailed discussion of the
limitations of the SAGE method is beyond the scope of this
article; suffice it to say that it is possible that functionally
important genes may be missing from the library due to low
mRNA expression levels, chance or because they lack the
target sequence for the tagging enzyme used in the SAGE
protocol [7]. In order to get to the final set of 378 CTL-spe-
cific genes Evans et al. [2] eliminated all transcripts that
were present at comparable levels in unrelated libraries.
This powerful approach seems to have validated itself by the
fact that TCR components and other principal T-cell
markers were present in the shortlist of 387 genes. The
method used is not unbiased, however. The choice of
libraries (in this case cerebellum, ovary epithelium, and a
panel of tumor cell lines that were not specified further),
data quality, and the algorithms used for comparison can be
expected to have an enormous impact on the results
obtained. It is easy to see how functionally important genes
might get lost because they are expressed at sufficiently high
levels in one of the cell or tissue types used for comparison.
A list of cell-type-specific genes derived by this method of
successive  in silico subtraction defines a cell-type-specific
gene-expression pattern against the transcriptional back-
ground of the cell or tissue types used for comparison. It is
not a list of all genes relevant for cell-type-specific function. 
The major finding of the Evans et al. study [2] is that among
the 387 CTL-specific transcripts 27% of the known genes
encoded cell-surface molecules, whereas only 2% of the
unknown genes showed some potential in that regard. The
implication is that the catalog of CTL surface molecules is
close to being complete. While it is not unreasonable to
assume that the concerted efforts over the last two decades
to characterize surface molecules on leukocytes have led to
a situation where most CTL-specific surface molecules are
known [8], some questions remain. Is this finding unique
for CTLs (or for leukocytes in general)? What would be the
result of a similar analysis in, for instance, ovary epithe-
lium? Were there unknown cell-surface molecules in the
CTL SAGE library? If so, at what point of the stepwise sub-
traction process did these transcripts get eliminated? It has
been noted that leukocytes share many surface molecules
with neuronal cells and epithelial cells [8], the very cells
used for subtraction by Evans et al. [2]. An alternative
experimental approach to analyzing the incidence of
unknown cell-surface molecules might be to generate SAGE
libraries from microsomal and free-ribosomal mRNA pools
generated through equilibrium density centrifugation. This
approach has been demonstrated to discriminate secretory
and cell-surface molecules from nonsecretory proteins quite
efficiently [9,10]. One would expect a significantly lower
percentage of unknown transcripts in the secretory/surface
molecule fraction.
Only the CTL SAGE library was actually generated by Evans
et al. [2]. The other libraries used for comparison were
derived from publicly available databases. Open access to
primary gene-expression data is essential, not only for
enabling researchers to reproduce published analyses, but
also to allow for novel experimental approaches that incor-
porate relevant data generated by others. Important infor-
mation can be gained by comparing genome-wide
expression data across large numbers of samples. In a
recent, extreme example, 3,283 DNA microarrays from
human, Drosophila, Caenorhabditis elegans and yeast were
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co-expressed genes [11]. SAGE data have been publicly avail-
able on SAGEMap [12,13] for a number of years. Microarray
data are far more complex, but a standard for the annotation
of microarray data (Minimal Information About a Microarray
Experiment; MIAME) [14] and a platform-independent data
exchange format (Microarray Gene Expression Markup Lan-
guage; MAGE-ML) [15] have been developed. Furthermore,
public repositories for microarray data such as ArrayExpress
[16,17] and GeoBus [18,19] are now available.
SAGE has the advantage over current microarray technol-
ogy of measuring absolute transcript abundance. Neverthe-
less, there are some limitations as to what can be said about
the T-cell surface by studying mRNA levels. First, for a
number of surface molecules, such as CD45, a variety of
functionally important splice variants have been described
[20] that cannot be distinguished by the 3 SAGE tag.
Second, mRNA levels correlate poorly with protein abun-
dance [21]. Third, posttranslational protein modifications
can be functionally relevant; for example, glycosylation of
CD8 has been demonstrated to affect thymocyte selection by
influencing activation thresholds [22]. Fourth, T-cell activa-
tion involves re-localization of surface molecules leading to
the formation of the immunological synapse, a supramolec-
ular cluster at the contact zone between antigen-presenting
cell and the T cell [23]. These early events precede changes
in gene expression.
Finally, it seems important to note that the T-cell surface is
an abstraction. T cells comprise quite different subsets of
cells at variable activation states. As pointed out by Evans et
al. [2], the finding that most of the molecules on the T-cell
surface appear to be known applies strictly only to a resting
CD8+ T-cell clone in vitro. ‘The T-cell surface - how well do
we know it?’ is an important question on our way into the
post-genomic era of immunology. But even with complete
lists of the genes expressed in certain T-cell subpopulations,
much more needs to be learned about the regulation and
complex interactions of the proteins they encode. We are
just scratching the (T cell) surface.
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